Public Health England
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2013-04-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nta.nhs.uk
Hepatitis B Vaccination in Infants
Phase 4
Completed
- Conditions
- Pneumococcal DiseaseDiphtheria, Tetanus and PertussisMeningococcal DiseaseHaemophilus Influenzae Serotype b DiseaseHepatitis b
- Interventions
- Biological: NeisVac-CBiological: MenitorixBiological: Menjugate
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 300
- Registration Number
- NCT01896596
- Locations
- 🇬🇧
St George's Vaccien Institute, London, United Kingdom
Ethnicity Data in HIV Positive Men Who Have Sex With Men
Withdrawn
- Conditions
- HIV
- First Posted Date
- 2011-01-17
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Public Health England
- Registration Number
- NCT01277458
- Locations
- 🇬🇧
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
Comparison of Two Meningococcal ACWY Conjugate Vaccines
Phase 2
Completed
- Conditions
- Meningococcal Meningitis
- Interventions
- Biological: MenACWY-TTBiological: Menveo
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 91
- Registration Number
- NCT01192997
- Locations
- 🇬🇧
Health Protection Agency, Immunisation Department, Colindale, London, United Kingdom
🇬🇧Multiple General Practice surgeries, Hertford, Hertfordshire, United Kingdom
A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza
Completed
- Conditions
- H1N1 Virus
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2010-09-01
- Lead Sponsor
- Public Health England
- Registration Number
- NCT01192958
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
Completed
- Conditions
- TuberculosisLatent Tuberculosis
- First Posted Date
- 2010-07-14
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 10000
- Registration Number
- NCT01162265
- Locations
- 🇬🇧
Ealing Hospital, Southall, London, United Kingdom
🇬🇧St George's Hospital, Tooting, London, United Kingdom
🇬🇧Homerton Hospital, London, United Kingdom
A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci
Completed
- Conditions
- Pneumococcal Disease
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 450
- Registration Number
- NCT01040143
- Locations
- 🇬🇧
Health Protection Agency, London, United Kingdom
Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls
Phase 4
Completed
- Conditions
- HPV Infections
- Interventions
- Biological: CervarixBiological: Gardasil
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 400
- Registration Number
- NCT00956553
- Locations
- 🇬🇧
Professor Elizabeth Miller, Gloucester, United Kingdom
🇬🇧Public Health England, London, United Kingdom
Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life
Phase 4
Completed
- Conditions
- Meningococcal InfectionsPneumococcal Infections
- Interventions
- Biological: Menjugate (Meningococcal C conjugate vaccine)Biological: NeisVacC (Meningococcal C conjugate vaccine)
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 130
- Registration Number
- NCT00625677
- Locations
- 🇬🇧
Health Protection Agency, London, United Kingdom
A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years
Completed
- Conditions
- Haemophilus Infections
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 500
- Registration Number
- NCT00625118
- Locations
- 🇬🇧
Health Protection Agency, London, United Kingdom
A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix
Phase 4
Completed
- Conditions
- Vaccination
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 30
- Registration Number
- NCT00503165
- Locations
- 🇬🇧
Health Protection Agency, Manchester Laboratory., Manchester, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath